Improved Myeloma Treatment Is Detailed
From Times Staff and Wire Reports
An unusually intensive assault on multiple myeloma cancer using two rounds of high-dose chemotherapy followed each time by a stem cell transplant appears to double patients’ long-term chances of survival, French researchers said Wednesday.
Although the approach is not a cure, doctors say the results are encouraging for victims of this usually lethal cancer of the bone marrow.
The researchers found that after seven years, 42% of patients who got the double treatment were still alive, compared with 21% of those who received the standard single round of chemotherapy plus a transplant.
